EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Ophthalmic Artificial Intelligence under the European Union Medical Device Regulation and Artificial Intelligence Act: Reclassification, Compliance, and Clinical Implications

Polat Goktas, Andrzej Grzybowski

Ophthalmology Science · 2026-12 · 6 (12) · 101402

DOI: 10.1016/j.xops.2026.101402 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ophthalmology Science, 2026-12. Verfasst von Polat Goktas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Engineering and Natural Sciences, Sabancı University, Istanbul, Türkiye. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Topic: How do the European Union (EU) Medical Device Regulation (MDR) (Regulation [EU] 2017/745) and the Artificial Intelligence Act (AI Act) (Regulation [EU] 2024/1689) jointly regulate artificial intelligence (AI)‑enabled ophthalmic medical devices, and what are the implications for device classification, regulatory compliance, and clinical implementation? Clinical Relevance: Artificial intelligence‑enabled ophthalmic medical devices, particularly Software as a Medical Device, are increasingly used for screening, diagnosis, and management of diabetic retinopathy, glaucoma, and age-related macular degeneration. As these technologies enter routine practice, understanding the complementary requirements of the MDR and AI Act is essential for ensuring patient safety, regulatory compliance, and trustworthy AI implementation.

Methods

This narrative review synthesizes peer-reviewed literature, EU legislation, regulatory guidance, and policy reports on AI-enabled ophthalmic medical devices. Evidence from major scientific databases and official EU sources was reviewed thematically to examine device classification, conformity assessment, high-risk AI requirements, transparency, postmarket surveillance, and emerging regulatory challenges.

Results

Most AI-enabled ophthalmic medical devices are classified as Class IIa, IIb, or III under the MDR and require notified body conformity assessment before Conformité Européenne marking. Under Article 6 of the AI Act, many also qualify as high-risk AI systems because they are safety components of MDR-regulated devices requiring third-party assessment. Manufacturers must, therefore, comply with both regulations, including requirements for risk management, data governance, technical documentation, transparency, human oversight, robustness, cybersecurity, and postmarket monitoring throughout the AI lifecycle. The implementation of the European Database on Medical Devices is expected to further strengthen regulatory transparency and postmarket oversight.

Conclusions

The MDR and AI Act establish a complementary regulatory framework that combines medical device safety requirements with AI-specific governance. This review clarifies their interaction and provides practical guidance for clinicians, manufacturers, researchers, and regulators involved in the development, evaluation, and implementation of ophthalmic AI in Europe. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Schlagwörter

Stichwörter der Autor:innen

AI ActArtificial intelligenceMedical device legislationOphthalmologySoftware as a medical device

Autor:innen und Institutionen

  • Faculty of Engineering and Natural Sciences, Sabancı University, Istanbul, Türkiye.
  • Department of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland.
  • Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznan, Poland.

Zitieren

APA

Goktas, P., & Grzybowski, A. (2026). Ophthalmic Artificial Intelligence under the European Union Medical Device Regulation and Artificial Intelligence Act: Reclassification, Compliance, and Clinical Implications. Ophthalmology Science, 6(12), 101402. https://doi.org/10.1016/j.xops.2026.101402

Vancouver

Goktas P, Grzybowski A. Ophthalmic Artificial Intelligence under the European Union Medical Device Regulation and Artificial Intelligence Act: Reclassification, Compliance, and Clinical Implications. Ophthalmology Science. 2026;6(12):101402. doi:10.1016/j.xops.2026.101402

BibTeX
@article{Goktas2026,
  author = {Goktas, Polat and Grzybowski, Andrzej},
  title = {Ophthalmic Artificial Intelligence under the European Union Medical Device Regulation and Artificial Intelligence Act: Reclassification, Compliance, and Clinical Implications},
  journal = {Ophthalmology Science},
  year = {2026},
  volume = {6},
  number = {12},
  pages = {101402},
  doi = {10.1016/j.xops.2026.101402}
}
Kostenlos starten →